Literature DB >> 24206446

Assessment of the validity of a multigene analysis in the diagnostics of inflammatory bowel disease.

J T Bjerrum1, C Nyberg, J Olsen, O H Nielsen.   

Abstract

OBJECTIVES: The findings of a previous multigene study indicated that the expression of a panel of seven specific genes had strong differential power regarding inflammatory bowel disease (IBD) versus non-IBD, as well as ulcerative colitis (UC) versus Crohn's disease (CD). This prospective confirmatory study based on an independent patient cohort from a national Danish IBD centre was conducted in an attempt to verify these earlier observations. DESIGN, SETTING AND PARTICIPANTS: A total of 119 patients were included in the study (CD, UC and controls). Three mucosal biopsies were retrieved from the left side of the colon of each patient. RNA was extracted, and RT-PCR was performed to retain expression profiles from the seven selected genes. Expression data from the training set (18 CD, 20 UC and 20 controls) were used to build a classification model, using quadratic discriminant analysis, and data from the test set (20 CD, 21 UC and 20 controls) were used to test the validity of the model.
RESULTS: The present investigation did not confirm the previous observation that a panel of seven specific genes is able to distinguish between patients with CD and UC, whereas the discriminative power for IBD versus control subjects was substantiated.
CONCLUSION: Our results fail to demonstrate that the previously identified seven-gene classification model is able to discriminate between CD and UC but suggest that the gene panel merely discriminates between inflamed and noninflamed colonic tissue. Thus, a reliable and simple diagnostic tool is still warranted for optimal diagnosis and treatment of patients with IBD, especially the subgroup with unclassified disease.
© 2013 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  Crohn's disease; colonic mucosal biopsy; diagnostics; gene expression; ulcerative colitis

Mesh:

Substances:

Year:  2013        PMID: 24206446     DOI: 10.1111/joim.12160

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

1.  Upregulation of PD-1 follows tumour development in the AOM/DSS model of inflammation-induced colorectal cancer in mice.

Authors:  Mohammad Yassin; Zuzanna Sadowska; Ditte Djurhuus; Brian Nielsen; Peter Tougaard; Jørgen Olsen; Anders Elm Pedersen
Journal:  Immunology       Date:  2019-09       Impact factor: 7.397

Review 2.  Inflammatory Bowel Disease-Unclassified in Children: Diagnosis and Pharmacological Management.

Authors:  Giulia D'Arcangelo; Marina Aloi
Journal:  Paediatr Drugs       Date:  2017-04       Impact factor: 3.022

Review 3.  The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs.

Authors:  Jan Korbecki; Iwona Szatkowska; Patrycja Kupnicka; Wojciech Żwierełło; Katarzyna Barczak; Iwona Poziomkowska-Gęsicka; Jerzy Wójcik; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

4.  Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals.

Authors:  Jacob Tveiten Bjerrum; Yulan Wang; Fuhua Hao; Mehmet Coskun; Christian Ludwig; Ulrich Günther; Ole Haagen Nielsen
Journal:  Metabolomics       Date:  2014-06-01       Impact factor: 4.290

Review 5.  Dr. Jekyll and Mr. Hyde: MAP17's up-regulation, a crosspoint in cancer and inflammatory diseases.

Authors:  José M García-Heredia; Amancio Carnero
Journal:  Mol Cancer       Date:  2018-04-12       Impact factor: 27.401

6.  Upregulation of REG IV gene in human intestinal epithelial cells by lipopolysaccharide via downregulation of microRNA-24.

Authors:  Shin Takasawa; Chikatsugu Tsuchida; Sumiyo Sakuramoto-Tsuchida; Tomoko Uchiyama; Mai Makino; Akiyo Yamauchi; Asako Itaya-Hironaka
Journal:  J Cell Mol Med       Date:  2022-08-09       Impact factor: 5.295

7.  Characterization of the enhancer and promoter landscape of inflammatory bowel disease from human colon biopsies.

Authors:  Mette Boyd; Malte Thodberg; Morana Vitezic; Jette Bornholdt; Kristoffer Vitting-Seerup; Yun Chen; Mehmet Coskun; Yuan Li; Bobby Zhao Sheng Lo; Pia Klausen; Pawel Jan Schweiger; Anders Gorm Pedersen; Nicolas Rapin; Kerstin Skovgaard; Katja Dahlgaard; Robin Andersson; Thilde Bagger Terkelsen; Berit Lilje; Jesper Thorvald Troelsen; Andreas Munk Petersen; Kim Bak Jensen; Ismail Gögenur; Peter Thielsen; Jakob Benedict Seidelin; Ole Haagen Nielsen; Jacob Tveiten Bjerrum; Albin Sandelin
Journal:  Nat Commun       Date:  2018-04-25       Impact factor: 14.919

8.  Cytoglobin affects tumorigenesis and the expression of ulcerative colitis-associated genes under chemically induced colitis in mice.

Authors:  Mohammad Yassin; Hannelouise Kissow; Ben Vainer; Philomeena Daphne Joseph; Anders Hay-Schmidt; Jørgen Olsen; Anders Elm Pedersen
Journal:  Sci Rep       Date:  2018-05-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.